Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 09:56 am Sale | 2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 903,412 9.990% | -1,015,547 (-52.92%) | Filing History |
| 2024-02-06 09:52 am Purchase | 2023-12-31 | 13G | Clearmind Medicine Inc. CMND | Mitchell P. Kopin | 88,925 4.990% | 88,925 (New Position) | Filing History |
| 2024-02-02 4:10 pm Purchase | 2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL | Mitchell P. Kopin | 2,000 4.000% | 2,000 (New Position) | Filing History |
| 2023-11-27 06:10 am Purchase | 2023-11-16 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 4,676 4.990% | 4,676 (New Position) | Filing History |
| 2023-08-11 4:18 pm Purchase | 2023-08-04 | 13G | NAYA Biosciences, Inc. NAYA | Mitchell P. Kopin | 15,333 7.100% | 15,333 (New Position) | Filing History |
| 2023-08-10 4:03 pm Purchase | 2023-08-01 | 13G | DMK Pharmaceuticals Corporation DMKPQ | Mitchell P. Kopin | 650,000 7.600% | 650,000 (New Position) | Filing History |
| 2023-07-14 5:27 pm Purchase | 2023-07-06 | 13G | Allarity Therapeutics, Inc. ALLR | Mitchell P. Kopin | 75 4.990% | 75 (New Position) | Filing History |
| 2023-06-30 4:10 pm Purchase | 2023-06-22 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 28,470 4.200% | 28,470 (New Position) | Filing History |
| 2023-06-01 5:23 pm Purchase | 2023-05-23 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 960 4.990% | 960 (New Position) | Filing History |
| 2023-05-25 4:13 pm Purchase | 2023-05-16 | 13G | OncoSec Medical Incorporated ONCS | Mitchell P. Kopin | 313,158 4.990% | 313,158 (New Position) | Filing History |
| 2023-04-28 4:31 pm Purchase | 2023-04-19 | 13G | Allarity Therapeutics, Inc. ALLR | Mitchell P. Kopin | 17 4.200% | 17 (New Position) | Filing History |
| 2023-04-19 5:14 pm Purchase | 2023-04-10 | 13G | SenesTech, Inc. SNES | Mitchell P. Kopin | 1,284 4.990% | 1,284 (New Position) | Filing History |
| 2023-04-14 4:24 pm Purchase | 2023-04-06 | 13G | Clearmind Medicine Inc. CMND | Mitchell P. Kopin | 12,821 6.300% | 12,821 (New Position) | Filing History |
| 2023-02-24 4:27 pm Unchanged | 2023-02-15 | 13G | Atlis Motor Vehicles, Inc. AMV | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-23 5:11 pm Purchase | 2023-02-14 | 13G | Top Ships Inc. TOPS | Mitchell P. Kopin | 86,623 4.990% | 86,623 (New Position) | Filing History |
| 2023-02-21 06:02 am Purchase | 2023-02-09 | 13G | Revelation Biosciences, Inc. REVB | Mitchell P. Kopin | 128 4.990% | 128 (New Position) | Filing History |
| 2023-02-17 4:43 pm Purchase | 2023-02-08 | 13G | OCEANPAL INC PAR $0.01 SVRN | Mitchell P. Kopin | 2,742,170 9.990% | 2,742,170 (New Position) | Filing History |
| 2023-02-16 4:21 pm Purchase | 2023-02-07 | 13G | Sintx Technologies, Inc. SINT | Mitchell P. Kopin | 598 4.500% | 598 (New Position) | Filing History |
| 2023-02-13 06:39 am Purchase | 2023-02-03 | 13G | Tenax Therapeutics, Inc. TENX | Mitchell P. Kopin | 5,997 4.990% | 5,997 (New Position) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | Pulmatrix, Inc. PULM | Mitchell P. Kopin | 100,324 2.700% | 100,324 (New Position) | Filing History |